Review article · 2026 · Open access
Interventions for negative symptoms in schizophrenia: efficacy and clinical interpretability in a meta-analysis of 451 randomized controlled trials
Molecular Psychiatry, 31(8), 4259–4269 · Published 23 March 2026 · DOI 10.1038/s41380-026-03543-1
In brief
“Interventions for negative symptoms in schizophrenia: efficacy and clinical interpretability in a meta-analysis of 451 randomized controlled trials” is a 2026 review article by Stefano Damiani and 24 co-authors, published in Molecular Psychiatry. OpenAlex counts 13 citations as of 17 November 2026, which puts it in the top 2% of works published in 2026 by citations. It is open access under a CC BY licence: the full text is free to read at Molecular Psychiatry.
- Citations
- 13
- Most cited in
- 2026 (13)
- Field-weighted impact
- 10.56
- References
- 63
- Authors
- 25
Abstract
Negative symptoms (avolition, anhedonia, asociality, blunted affect, and alogia) are among the most disabling features of schizophrenia spectrum disorders. In the absence of treatment consensus guidelines, this PRISMA-compliant meta-analysis (PROSPERO: CRD42024613967) evaluated efficacy and clinical significance of interventions targeting this dimension. Web of Science/PsycInfo databases were searched from inception to December 2024. Five categories (antipsychotics, other pharmacological agents, brain stimulation, psychosocial, and lifestyle interventions) were analyzed across short/middle/long follow-up times. Categories were divided into 27 subcategories (e.g., 'other pharmacological agents' divided in 14 subcategories including antidepressants, antibiotics, immunomodulators) regardless of follow-up, assessing evidence with GRADE criteria. The primary outcome was the change in negative symptom severity, measured with validated scales (PANSS/SANS/BPRS/CAINS/BNSS) as standardized mean differences (SMD). A clinically meaningful SMD threshold was estimated from the regression between SMD and one-point reductions on the Clinical Global Impression-Severity (CGI-S) scale. This study meta-analyzed 451 trials (n = 42566). The clinically meaningful threshold, obtained from 122 trials reporting CGI-S, was SMD ≥ 0.457. In 214 high-quality studies (n = 19746), 2 category-by-follow-up combinations and 16 subcategories showed significant improvements. Clinically meaningful SMDs for subcategories were antibiotics (0.95; CI: 0.18-1.71; moderate-GRADE), integrated psychosocial interventions (0.93; CI: 0.53-1.33; very-low-GRADE), antidepressants (0.76; CI: 0.33-1.19; moderate-GRADE), physical activity (0.68; CI: 0.39-0.96; very-low-GRADE), transcranial current stimulation (0.52; CI: 0.17-0.86; low-GRADE), and immunomodulators (0.47; CI: 0.26-0.67; high-GRADE), typically as adjuncts to antipsychotics. Heterogeneity was the main limitation. While selected interventions may yield meaningful improvements, more rigorous designs are needed to identify reliable, personalized and scalable treatment options.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Damiani, S., Stefanelli, R., Fortea, L., D'Imperio, A., Calò, M., Casarini, F., Crippa, A., Esposito, C. M., Leggi, R., Marika, O., Patron, S., Peviani, A., Piccolo, A., Provenzani, U., Santilli, F. A., Spallarossa, C., Papanastasiou, E., Cella, M., Patel, R., . . . Fusar‐Poli, P. (2026). Interventions for negative symptoms in schizophrenia: efficacy and clinical interpretability in a meta-analysis of 451 randomized controlled trials. Molecular Psychiatry, 31(8), 4259–4269. https://doi.org/10.1038/s41380-026-03543-1
MLA 9
Damiani, Stefano, et al. “Interventions for negative symptoms in schizophrenia: efficacy and clinical interpretability in a meta-analysis of 451 randomized controlled trials.” Molecular Psychiatry, vol. 31, no. 8, 2026, pp. 4259–4269. https://doi.org/10.1038/s41380-026-03543-1.
Chicago
Damiani, Stefano, Riccardo Stefanelli, Lydia Fortea, Aldo D'Imperio, Matteo Calò, Francesco Casarini, Andrea Crippa, et al. 2026. “Interventions for negative symptoms in schizophrenia: efficacy and clinical interpretability in a meta-analysis of 451 randomized controlled trials.” Molecular Psychiatry 31 (8): 4259–4269. https://doi.org/10.1038/s41380-026-03543-1.
Harvard
Damiani, S. et al. (2026) ‘Interventions for negative symptoms in schizophrenia: efficacy and clinical interpretability in a meta-analysis of 451 randomized controlled trials’, Molecular Psychiatry, 31(8), pp. 4259–4269. doi:10.1038/s41380-026-03543-1.
IEEE
S. Damiani et al., “Interventions for negative symptoms in schizophrenia: efficacy and clinical interpretability in a meta-analysis of 451 randomized controlled trials,” Molecular Psychiatry, vol. 31, no. 8, pp. 4259–4269, 2026, doi: 10.1038/s41380-026-03543-1.
BibTeX
@article{damiani2026interventions,
title = {{Interventions for negative symptoms in schizophrenia: efficacy and clinical interpretability in a meta-analysis of 451 randomized controlled trials}},
author = {Damiani, Stefano and Stefanelli, Riccardo and Fortea, Lydia and D'Imperio, Aldo and Calò, Matteo and Casarini, Francesco and Crippa, Andrea and Esposito, Cecilia Maria and Leggi, Roberto and Marika, Orlandi and Patron, Sara and Peviani, Alessandro and Piccolo, Alessandro and Provenzani, Umberto and Santilli, Fabrizio Antonio and Spallarossa, Cecilia and Papanastasiou, Evangelos and Cella, Matteo and Patel, Rashmi and Solmi, Marco and Galderisi, Silvana and Leucht, Stefan and Stahl, Daniel R. and Raduà, Joaquim and Fusar‐Poli, Paolo},
journal = {Molecular Psychiatry},
year = {2026},
volume = {31},
number = {8},
pages = {4259--4269},
doi = {10.1038/s41380-026-03543-1},
url = {https://doi.org/10.1038/s41380-026-03543-1}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Topic and keywords
Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- schizophrenia
- negative symptoms
- treatment efficacy
- clinical significance
- antibiotics
- antidepressants
- immunomodulators
- physical activity
Work with this paper
Most-cited papers in Medicine
- Yaşlı Kadınlarda Üreme SağlığıDemet Kokanalı, Yaprak Engin Üstün · Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi · 2019 · 169,630 citations
- Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 CountriesHyuna Sung, Adalberto M. Filho, Mathieu Laversanne and 5 more · CA A Cancer Journal for Clinicians · 2021 · 119,885 citations
- “Mini-mental state”Marshal F. Folstein, Susan E. Folstein, Paul R. McHugh · Journal of Psychiatric Research · 1975 · 90,424 citations
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countriesFreddie Bray, Jacques Ferlay, Isabelle Soerjomataram and 3 more · CA A Cancer Journal for Clinicians · 2018 · 87,396 citations
- Hallmarks of Cancer: The Next GenerationDouglas Hanahan, Robert A. Weinberg · Cell · 2011 · 69,758 citations
Questions about this paper
How do I cite this paper in APA style?
Damiani, S., Stefanelli, R., Fortea, L., D'Imperio, A., Calò, M., Casarini, F., Crippa, A., Esposito, C. M., Leggi, R., Marika, O., Patron, S., Peviani, A., Piccolo, A., Provenzani, U., Santilli, F. A., Spallarossa, C., Papanastasiou, E., Cella, M., Patel, R., . . . Fusar‐Poli, P. (2026). Interventions for negative symptoms in schizophrenia: efficacy and clinical interpretability in a meta-analysis of 451 randomized controlled trials. Molecular Psychiatry, 31(8), 4259–4269. https://doi.org/10.1038/s41380-026-03543-1
How many times has this paper been cited?
13 times, according to OpenAlex on 17 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at Molecular Psychiatry: sign in and open the PDF from this page.
Who wrote this paper?
Stefano Damiani, Riccardo Stefanelli, Lydia Fortea, Aldo D'Imperio, Matteo Calò, Francesco Casarini, Andrea Crippa, Cecilia Maria Esposito, Roberto Leggi, Orlandi Marika, Sara Patron, Alessandro Peviani and 13 more.
What is the DOI of this paper?
10.1038/s41380-026-03543-1, permanently at https://doi.org/10.1038/s41380-026-03543-1. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 17 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.